FDA Adverse Event Malfunction Summary report: N

INRATION PT/INR TEST STRIPS

MDR report key: 3921948 · Received May 28, 2014

Report

Report Number
2027969-2014-00503
Event Type
Malfunction
Date Received
May 28, 2014
Date of Event
May 1, 2014
Report Date
May 12, 2014
Manufacturer
ALERE SAN DIEGO INC
Product Code
GJS
PMA / PMN Number
K092987
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

IT IS INDICATED THAT PRODUCT IS NOT RETURNING FOR EVALUATION. THEREFORE, INVESTIGATION OF THE COMPLAINT TO DETERMINE ROOT CAUSE CANNOT BE COMPLETED. SINCE THE PRODUCT ASSOCIATED WITH THE COMPLAINT WAS NOT RETURNED, A REVIEW OF IN-HOUSE TESTING DATA WAS PERFORMED. RETAIN STRIP TESTING RESULTS MET BOTH ACCURACY AND REPEATABILITY CRITERIA. THE PRODUCT PERFORMED AS EXPECTED AND NO PRODUCT DEFICIENCIES WERE OBSERVED. ALTHOUGH THE ROOT CAUSE ANALYSIS DID NOT INCLUDE RETURN TESTING, IMPROPER TECHNIQUES WERE IDENTIFIED IN THE COMPLAINT. THESE COULD NOT BE RULED OUT AS A CAUSE OF THE UNEXPECTED RESULTS. THE MANUFACTURING RECORDS FOR THE LOT WERE REVIEWED. THE LOT MET SPECIFICATIONS AND NO NON-CONFORMANCES WERE DOCUMENTED. NO FURTHER INVESTIGATION WILL BE PURSUED AT THIS TIME. BASED ON THE INFO AVAILABLE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT INRATIO RESULTS. RESULTS AS FOLLOWS. DATE: (B)(6) 2014; INRATIO: 2.4; RE-TEST: 3.3. TIME BETWEEN TESTS: 10 MINUTES. THERAPEUTIC RANGE: 3-3.5. PT SELF TESTER REPORTS MILKING THE FINGER AFTER FINGER STICK. CUSTOMER IS NOT SURE IF THE FIRST DROP OF BLOOD WAS USED TO OBTAIN THE INRATIO 2.4 RESULT. A DIFFERENT FINGER WAS USED TO OBTAIN THE 3.3 RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
314801 INRATION PT/INR TEST STRIPS PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO INC 100071 340746

Patients

Seq Age Sex Outcome Treatment
1 POTASSIUM (KLOR-CON) 10 MEQ (AS OF (B)(6) 2014)| ASPIRIN| WARFARIN 5MG/DAY 7 1MG M, W, F| FUROSEMIDE 120 MG (AS OF (B)(6) 2014)